Intelligence · Clinical Development
Pipeline search results
Programs matching “vortioxetine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 24 pipeline programs matching "vortioxetine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Vortioxetine
Takeda
TBI
1 trial -
Vortioxetine
Takeda
Generalized Anxiety Disorder
3 trials -
Vortioxetine
Takeda
Depressive Disorder, Major
5 trials -
Vortioxetine
COGNITION THERAPEUTICS INC
Major Depressive Disorder
1 trial -
Vortioxetine
Takeda
Treatment Outcome
1 trial -
Vortioxetine
Takeda
Major Depressive Disorder
9 trials -
Vortioxetine
The University of Hong Kong
Cannabis Use Disorder
1 trial -
Vortioxetine 10 mg/day
Takeda
Depressive Disorder, Major
2 trials -
Vortioxetine tablets
Takeda
Major Depressive Disorder
1 trial -
Vortioxetine
COGNITION THERAPEUTICS INC
Post-COVID-19 Condition
1 trial -
Vortioxetine
Takeda
Binge Eating Disorder
1 trial -
Vortioxetine (IV)
Takeda
Depressive Disorder, Major
1 trial -
vortioxetine (Lu AA21004)
Takeda
Depressive Disorder, Major
1 trial -
Bioequivalence clinical trial of two formulations of vortioxetine.
Laboratorios Tillomed Spain S.L.U
Healthy volunteers
1 trial -
Vortioxetine
Takeda
Severe Hepatic Impairment
1 trial -
Vortioxetine
Takeda
Healthy Adult Participants
1 trial -
Vortioxetine
Takeda
Healthy
1 trial -
Vortioxetine
Takeda
Unipolar Major Depression
1 trial -
Vortioxetine
Takeda
Depressive Disorder
1 trial -
Vortioxetine
Takeda
Type2 Diabetes
1 trial -
Vortioxetine
Takeda
Healthy Volunteers
1 trial -
Vortioxetine
Takeda
Schizophrenia
1 trial -
Vortioxetine 10 mg
Takeda
Age-related Cognitive Decline
1 trial -
vortioxetine
Takeda
Depression
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.